COVID-19 continues to dominate medical device industry news on MassDevice.
The pandemic is causing more major lawsuit settling — as well as efforts to offer more medtech to enable better management of the coronavirus.
Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five:
5. CureVac raises more than $200M in IPO
CureVac (NSDQ:CVAC) — a Germany-based biotech outfit — is developing a COVID-19 vaccine with backing from the Bill and Melinda Gates Foundation. Read the full story.
4. This telemedicine system could get medtech sales reps back to ORs
Avail Medsystem’s telemedicine system could prove a more efficient way for sales reps to sit in on surgeries, especially as the COVID-19 pandemic continues to hinder access to hospitals. Read the full story.
3. FDA clears ClearMask transparent surgical mask
Baltimore-based ClearMask touts its surgical mask as the first FDA-cleared fully transparent surgical mask for use in hospitals, clinics, schools, retail, hospitality and other settings. I could help improve visual communication among people working on the front lines in the pandemic. Read the full story.
2. FDA warns on false results for Thermo Fisher TaqPath COVID-19 testing kit
Results from the Thermo Fisher TaqPath COVID-19 Combo Kit may be false, based on two issues related to the test kit and the associated Applied Biosystems COVID-19 interpretive software, according to an FDA release. Read the full story.
1. Bayer settles 90% of Essure claims for $1.6B
Bayer claims that virtually all its U.S. Essure litigation is now resolved, adding that the company “sympathizes with all women who have experienced adverse health conditions, regardless of the cause, but the company continues to stand by the science supporting the safety and efficacy of Essure.” Read the full story.
